Dicumarol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dicumarol and what is the scope of freedom to operate?
Dicumarol
is the generic ingredient in one branded drug marketed by Lilly and Abbvie, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for dicumarol.
Summary for dicumarol
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 1 |
Patent Applications: | 6,516 |
DailyMed Link: | dicumarol at DailyMed |
Recent Clinical Trials for dicumarol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Bologna | Phase 4 |
Medical Subject Heading (MeSH) Categories for dicumarol
US Patents and Regulatory Information for dicumarol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | DICUMAROL | dicumarol | CAPSULE;ORAL | 005509-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | DICUMAROL | dicumarol | CAPSULE;ORAL | 005509-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |